�ݺ�ߣshows by User: KajalPradhan4

�ݺ�ߣshows by User: KajalPradhan4 / http://www.slideshare.net/images/logo.gif �ݺ�ߣshows by User: KajalPradhan4 / Thu, 08 Feb 2024 08:38:17 GMT �ݺ�ߣShare feed for �ݺ�ߣshows by User: KajalPradhan4 rheology, types of fluid flow, viscometer /slideshow/rheology-types-of-fluid-flow-viscometer/266214141 rheology-240208083817-71c0c770
rheology is the science that concerns with the flow of liquids and deformation of solids Different types of fluid flow]]>
rheology is the science that concerns with the flow of liquids and deformation of solids Different types of fluid flow]]> Thu, 08 Feb 2024 08:38:17 GMT /slideshow/rheology-types-of-fluid-flow-viscometer/266214141 KajalPradhan4@slideshare.net(KajalPradhan4) rheology, types of fluid flow, viscometer KajalPradhan4 rheology is the science that concerns with the flow of liquids and deformation of solids Different types of fluid flow <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/rheology-240208083817-71c0c770-thumbnail.jpg?width=120&height=120&fit=bounds" /> rheology is the science that concerns with the flow of liquids and deformation of solids Different types of fluid flow

rheology, types of fluid flow, viscometer from kajal pradhan

]]> 32 0 https://cdn.slidesharecdn.com/ss_thumbnails/rheology-240208083817-71c0c770-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Emulsion and Suspension.pptx /slideshow/emulsion-and-suspensionpptx/254425380 emulsionandsuspension-221123054021-f35a5178
An emulsion is similar to a suspension only in that it is a mixture of two components. That is where the similarities end, however. Unlike a suspension, which can consist of two components of any phase, an emulsion is a mixture of two liquids.]]>
An emulsion is similar to a suspension only in that it is a mixture of two components. That is where the similarities end, however. Unlike a suspension, which can consist of two components of any phase, an emulsion is a mixture of two liquids.]]> Wed, 23 Nov 2022 05:40:21 GMT /slideshow/emulsion-and-suspensionpptx/254425380 KajalPradhan4@slideshare.net(KajalPradhan4) Emulsion and Suspension.pptx KajalPradhan4 An emulsion is similar to a suspension only in that it is a mixture of two components. That is where the similarities end, however. Unlike a suspension, which can consist of two components of any phase, an emulsion is a mixture of two liquids. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/emulsionandsuspension-221123054021-f35a5178-thumbnail.jpg?width=120&height=120&fit=bounds" /> An emulsion is similar to a suspension only in that it is a mixture of two components. That is where the similarities end, however. Unlike a suspension, which can consist of two components of any phase, an emulsion is a mixture of two liquids.

Emulsion and Suspension.pptx from kajal pradhan

]]> 1441 0 https://cdn.slidesharecdn.com/ss_thumbnails/emulsionandsuspension-221123054021-f35a5178-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Why use the zebrafish in research.pptx /slideshow/why-use-the-zebrafish-in-researchpptx/254206695 whyusethezebrafishinresearch-221115043748-b13c67a1
zebrafish are a workhorse as a translatable research model. And there are a multitude of assays in which they’ve shown promise. The zebrafish is perhaps one of the most frequently used model organisms for genetic and developmental studies. The zebrafish is known for its unique regenerative abilities and rapid embryonic development. The scientific name of zebrafish is Danio rerio and it belongs to the minnow family, Cyprinidae. The fish got its common name from the presence of five uniform and pigmented horizontal stripes on the side of its body, which resemble the stripes of a zebra. The characteristic stripes of zebrafish are blue in colour and they extend from the gill cover to the end of the caudal fin. Scientists use fluorescent proteins as markers to more easily identify certain processes or reactions during microscopy research. Green fluorescent proteins (GFP), are used to create chimeric proteins which can be expressed in cells, tissues, and whole organisms. Using directed mutagenesis, fluorescence can emit in multiple wavelengths. Fluorescent proteins are critical to research involving embryonic and larval zebrafish since they are transparent and develop nearly all organs and musculoskeletal structures six days after fertilization. Transparent embryos thus allow researchers to observe organs or tissues marked with tissue specific expressions of fluorescent proteins as they develop. Dozens of transgenic zebrafish lines have been created which express fluorescent proteins in organs, glands, and other bodily structures. ]]>
zebrafish are a workhorse as a translatable research model. And there are a multitude of assays in which they’ve shown promise. The zebrafish is perhaps one of the most frequently used model organisms for genetic and developmental studies. The zebrafish is known for its unique regenerative abilities and rapid embryonic development. The scientific name of zebrafish is Danio rerio and it belongs to the minnow family, Cyprinidae. The fish got its common name from the presence of five uniform and pigmented horizontal stripes on the side of its body, which resemble the stripes of a zebra. The characteristic stripes of zebrafish are blue in colour and they extend from the gill cover to the end of the caudal fin. Scientists use fluorescent proteins as markers to more easily identify certain processes or reactions during microscopy research. Green fluorescent proteins (GFP), are used to create chimeric proteins which can be expressed in cells, tissues, and whole organisms. Using directed mutagenesis, fluorescence can emit in multiple wavelengths. Fluorescent proteins are critical to research involving embryonic and larval zebrafish since they are transparent and develop nearly all organs and musculoskeletal structures six days after fertilization. Transparent embryos thus allow researchers to observe organs or tissues marked with tissue specific expressions of fluorescent proteins as they develop. Dozens of transgenic zebrafish lines have been created which express fluorescent proteins in organs, glands, and other bodily structures. ]]> Tue, 15 Nov 2022 04:37:48 GMT /slideshow/why-use-the-zebrafish-in-researchpptx/254206695 KajalPradhan4@slideshare.net(KajalPradhan4) Why use the zebrafish in research.pptx KajalPradhan4 zebrafish are a workhorse as a translatable research model. And there are a multitude of assays in which they’ve shown promise. The zebrafish is perhaps one of the most frequently used model organisms for genetic and developmental studies. The zebrafish is known for its unique regenerative abilities and rapid embryonic development. The scientific name of zebrafish is Danio rerio and it belongs to the minnow family, Cyprinidae. The fish got its common name from the presence of five uniform and pigmented horizontal stripes on the side of its body, which resemble the stripes of a zebra. The characteristic stripes of zebrafish are blue in colour and they extend from the gill cover to the end of the caudal fin. Scientists use fluorescent proteins as markers to more easily identify certain processes or reactions during microscopy research. Green fluorescent proteins (GFP), are used to create chimeric proteins which can be expressed in cells, tissues, and whole organisms. Using directed mutagenesis, fluorescence can emit in multiple wavelengths. Fluorescent proteins are critical to research involving embryonic and larval zebrafish since they are transparent and develop nearly all organs and musculoskeletal structures six days after fertilization. Transparent embryos thus allow researchers to observe organs or tissues marked with tissue specific expressions of fluorescent proteins as they develop. Dozens of transgenic zebrafish lines have been created which express fluorescent proteins in organs, glands, and other bodily structures. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/whyusethezebrafishinresearch-221115043748-b13c67a1-thumbnail.jpg?width=120&height=120&fit=bounds" /> zebrafish are a workhorse as a translatable research model. And there are a multitude of assays in which they’ve shown promise. The zebrafish is perhaps one of the most frequently used model organisms for genetic and developmental studies. The zebrafish is known for its unique regenerative abilities and rapid embryonic development. The scientific name of zebrafish is Danio rerio and it belongs to the minnow family, Cyprinidae. The fish got its common name from the presence of five uniform and pigmented horizontal stripes on the side of its body, which resemble the stripes of a zebra. The characteristic stripes of zebrafish are blue in colour and they extend from the gill cover to the end of the caudal fin. Scientists use fluorescent proteins as markers to more easily identify certain processes or reactions during microscopy research. Green fluorescent proteins (GFP), are used to create chimeric proteins which can be expressed in cells, tissues, and whole organisms. Using directed mutagenesis, fluorescence can emit in multiple wavelengths. Fluorescent proteins are critical to research involving embryonic and larval zebrafish since they are transparent and develop nearly all organs and musculoskeletal structures six days after fertilization. Transparent embryos thus allow researchers to observe organs or tissues marked with tissue specific expressions of fluorescent proteins as they develop. Dozens of transgenic zebrafish lines have been created which express fluorescent proteins in organs, glands, and other bodily structures.

Why use the zebrafish in research.pptx from kajal pradhan

]]> 1017 0 https://cdn.slidesharecdn.com/ss_thumbnails/whyusethezebrafishinresearch-221115043748-b13c67a1-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Regulatory affairs overview.pptx /slideshow/regulatory-affairs-overviewpptx/252787458 guestlecture-220901075118-9ebf8995
Regulatory Affairs is a profession which has developed from the desire of governments to protect public health, by controlling the safety and efficacy of products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicines. ]]>
Regulatory Affairs is a profession which has developed from the desire of governments to protect public health, by controlling the safety and efficacy of products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicines. ]]> Thu, 01 Sep 2022 07:51:18 GMT /slideshow/regulatory-affairs-overviewpptx/252787458 KajalPradhan4@slideshare.net(KajalPradhan4) Regulatory affairs overview.pptx KajalPradhan4 Regulatory Affairs is a profession which has developed from the desire of governments to protect public health, by controlling the safety and efficacy of products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicines. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/guestlecture-220901075118-9ebf8995-thumbnail.jpg?width=120&height=120&fit=bounds" /> Regulatory Affairs is a profession which has developed from the desire of governments to protect public health, by controlling the safety and efficacy of products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicines.

Regulatory affairs overview.pptx from kajal pradhan

]]> 10390 0 https://cdn.slidesharecdn.com/ss_thumbnails/guestlecture-220901075118-9ebf8995-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Emollients.pptx /slideshow/emollientspptx/251789182 emollients-220516072726-d1c348da
Emollients are moisturising treatments applied directly to the skin to soothe and hydrate it. They cover the skin with a protective film to trap in moisture. Emollients are often used to help manage dry, itchy or scaly skin conditions such as eczema, psoriasis. Emollients are available as: Lotions – good for hairy or damaged areas of skin (such as weeping eczema) as they are thin and spread easily, but they're not very moisturising Sprays – good for hard-to-reach areas and for sore or infected skin that shouldn't be touched; quickly absorbed Creams – good for daytime use as they're not very greasy and are absorbed quickly Ointments – good for very dry, thickened skin and for night-time use as they are greasy, thick and very moisturising; they're usually free of preservatives so are suitable for sensitive skin, but they shouldn't be used on weeping eczema Bath Oils and Shower Products Soap Substitutes Leave-on emollients Emollient lotions, sprays, creams and ointments should be applied directly to the skin. They should be smoothed, not rubbed, into the skin gently and in the same direction that your hair grows, to help prevent hair follicles from getting blocked. They can be used to replace lost moisture whenever your skin feels dry or tight. They are very safe and you can't overuse them. You may need to experiment with different emollients or try a combination. For example, you may decide to use a cream during the day and an ointment at night. Leave-on emollients Emollient lotions, sprays, creams and ointments should be applied directly to the skin. They should be smoothed, not rubbed, into the skin gently and in the same direction that your hair grows, to help prevent hair follicles from getting blocked. They can be used to replace lost moisture whenever your skin feels dry or tight. They are very safe and you can't overuse them. You may need to experiment with different emollients or try a combination. For example, you may decide to use a cream during the day and an ointment at night. Leave-on emollients Emollient lotions, sprays, creams and ointments should be applied directly to the skin. They should be smoothed, not rubbed, into the skin gently and in the same direction that your hair grows, to help prevent hair follicles from getting blocked. They can be used to replace lost moisture whenever your skin feels dry or tight. They are very safe and you can't overuse them. You may need to experiment with different emollients or try a combination. For example, you may decide to use a cream during the day and an ointment at night. Leave-on emollients Emollient lotions, sprays, creams and ointments should be applied directly to the skin. They should be smoothed, not rubbed, into the skin gently and in the same direction that your hair grows, to help prevent hair follicles from getting blocked. They can be used to replace lost moisture whenever your skin feels dry or tight. ]]>
Emollients are moisturising treatments applied directly to the skin to soothe and hydrate it. They cover the skin with a protective film to trap in moisture. Emollients are often used to help manage dry, itchy or scaly skin conditions such as eczema, psoriasis. Emollients are available as: Lotions – good for hairy or damaged areas of skin (such as weeping eczema) as they are thin and spread easily, but they're not very moisturising Sprays – good for hard-to-reach areas and for sore or infected skin that shouldn't be touched; quickly absorbed Creams – good for daytime use as they're not very greasy and are absorbed quickly Ointments – good for very dry, thickened skin and for night-time use as they are greasy, thick and very moisturising; they're usually free of preservatives so are suitable for sensitive skin, but they shouldn't be used on weeping eczema Bath Oils and Shower Products Soap Substitutes Leave-on emollients Emollient lotions, sprays, creams and ointments should be applied directly to the skin. They should be smoothed, not rubbed, into the skin gently and in the same direction that your hair grows, to help prevent hair follicles from getting blocked. They can be used to replace lost moisture whenever your skin feels dry or tight. They are very safe and you can't overuse them. You may need to experiment with different emollients or try a combination. For example, you may decide to use a cream during the day and an ointment at night. Leave-on emollients Emollient lotions, sprays, creams and ointments should be applied directly to the skin. They should be smoothed, not rubbed, into the skin gently and in the same direction that your hair grows, to help prevent hair follicles from getting blocked. They can be used to replace lost moisture whenever your skin feels dry or tight. They are very safe and you can't overuse them. You may need to experiment with different emollients or try a combination. For example, you may decide to use a cream during the day and an ointment at night. Leave-on emollients Emollient lotions, sprays, creams and ointments should be applied directly to the skin. They should be smoothed, not rubbed, into the skin gently and in the same direction that your hair grows, to help prevent hair follicles from getting blocked. They can be used to replace lost moisture whenever your skin feels dry or tight. They are very safe and you can't overuse them. You may need to experiment with different emollients or try a combination. For example, you may decide to use a cream during the day and an ointment at night. Leave-on emollients Emollient lotions, sprays, creams and ointments should be applied directly to the skin. They should be smoothed, not rubbed, into the skin gently and in the same direction that your hair grows, to help prevent hair follicles from getting blocked. They can be used to replace lost moisture whenever your skin feels dry or tight. ]]> Mon, 16 May 2022 07:27:26 GMT /slideshow/emollientspptx/251789182 KajalPradhan4@slideshare.net(KajalPradhan4) Emollients.pptx KajalPradhan4 Emollients are moisturising treatments applied directly to the skin to soothe and hydrate it. They cover the skin with a protective film to trap in moisture. Emollients are often used to help manage dry, itchy or scaly skin conditions such as eczema, psoriasis. Emollients are available as: Lotions – good for hairy or damaged areas of skin (such as weeping eczema) as they are thin and spread easily, but they're not very moisturising Sprays – good for hard-to-reach areas and for sore or infected skin that shouldn't be touched; quickly absorbed Creams – good for daytime use as they're not very greasy and are absorbed quickly Ointments – good for very dry, thickened skin and for night-time use as they are greasy, thick and very moisturising; they're usually free of preservatives so are suitable for sensitive skin, but they shouldn't be used on weeping eczema Bath Oils and Shower Products Soap Substitutes Leave-on emollients Emollient lotions, sprays, creams and ointments should be applied directly to the skin. They should be smoothed, not rubbed, into the skin gently and in the same direction that your hair grows, to help prevent hair follicles from getting blocked. They can be used to replace lost moisture whenever your skin feels dry or tight. They are very safe and you can't overuse them. You may need to experiment with different emollients or try a combination. For example, you may decide to use a cream during the day and an ointment at night. Leave-on emollients Emollient lotions, sprays, creams and ointments should be applied directly to the skin. They should be smoothed, not rubbed, into the skin gently and in the same direction that your hair grows, to help prevent hair follicles from getting blocked. They can be used to replace lost moisture whenever your skin feels dry or tight. They are very safe and you can't overuse them. You may need to experiment with different emollients or try a combination. For example, you may decide to use a cream during the day and an ointment at night. Leave-on emollients Emollient lotions, sprays, creams and ointments should be applied directly to the skin. They should be smoothed, not rubbed, into the skin gently and in the same direction that your hair grows, to help prevent hair follicles from getting blocked. They can be used to replace lost moisture whenever your skin feels dry or tight. They are very safe and you can't overuse them. You may need to experiment with different emollients or try a combination. For example, you may decide to use a cream during the day and an ointment at night. Leave-on emollients Emollient lotions, sprays, creams and ointments should be applied directly to the skin. They should be smoothed, not rubbed, into the skin gently and in the same direction that your hair grows, to help prevent hair follicles from getting blocked. They can be used to replace lost moisture whenever your skin feels dry or tight. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/emollients-220516072726-d1c348da-thumbnail.jpg?width=120&height=120&fit=bounds" /> Emollients are moisturising treatments applied directly to the skin to soothe and hydrate it. They cover the skin with a protective film to trap in moisture. Emollients are often used to help manage dry, itchy or scaly skin conditions such as eczema, psoriasis. Emollients are available as: Lotions – good for hairy or damaged areas of skin (such as weeping eczema) as they are thin and spread easily, but they're not very moisturising Sprays – good for hard-to-reach areas and for sore or infected skin that shouldn't be touched; quickly absorbed Creams – good for daytime use as they're not very greasy and are absorbed quickly Ointments – good for very dry, thickened skin and for night-time use as they are greasy, thick and very moisturising; they're usually free of preservatives so are suitable for sensitive skin, but they shouldn't be used on weeping eczema Bath Oils and Shower Products Soap Substitutes Leave-on emollients Emollient lotions, sprays, creams and ointments should be applied directly to the skin. They should be smoothed, not rubbed, into the skin gently and in the same direction that your hair grows, to help prevent hair follicles from getting blocked. They can be used to replace lost moisture whenever your skin feels dry or tight. They are very safe and you can't overuse them. You may need to experiment with different emollients or try a combination. For example, you may decide to use a cream during the day and an ointment at night. Leave-on emollients Emollient lotions, sprays, creams and ointments should be applied directly to the skin. They should be smoothed, not rubbed, into the skin gently and in the same direction that your hair grows, to help prevent hair follicles from getting blocked. They can be used to replace lost moisture whenever your skin feels dry or tight. They are very safe and you can't overuse them. You may need to experiment with different emollients or try a combination. For example, you may decide to use a cream during the day and an ointment at night. Leave-on emollients Emollient lotions, sprays, creams and ointments should be applied directly to the skin. They should be smoothed, not rubbed, into the skin gently and in the same direction that your hair grows, to help prevent hair follicles from getting blocked. They can be used to replace lost moisture whenever your skin feels dry or tight. They are very safe and you can't overuse them. You may need to experiment with different emollients or try a combination. For example, you may decide to use a cream during the day and an ointment at night. Leave-on emollients Emollient lotions, sprays, creams and ointments should be applied directly to the skin. They should be smoothed, not rubbed, into the skin gently and in the same direction that your hair grows, to help prevent hair follicles from getting blocked. They can be used to replace lost moisture whenever your skin feels dry or tight.

Emollients.pptx from kajal pradhan

]]> 1303 0 https://cdn.slidesharecdn.com/ss_thumbnails/emollients-220516072726-d1c348da-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 The Thalidomide tragedy.pptx /slideshow/the-thalidomide-tragedypptx/251639143 thethalidomidetragedy-220422053640
Thalidomide was first developed by CIBA, a Swiss pharmaceutical company in the early 1950s, and subsequently introduced as Contergan by Chemi Grunenthal. The drug was initially advertised as a sedative which would allow users to undergo a deep sleep in the absence of a hangover and with a reduced risk of developing drug dependency. At the time, basic testing was done on the drug, and it was considered not to have any toxic effects on humans. However, unlike today’s level of rigorous testing, the drug was not analyzed for any potentially dangerous teratogenic effects. In the 1950s, scientists did not know that the effects of a drug could be passed through the placental barrier and harm a foetus in the womb, so the use of medications during pregnancy was not strictly controlled. And in the case of thalidomide, no tests were done involving pregnant women. As the drug was traded under so many different names in 49 countries, it took five years for the connection between thalidomide taken by pregnant women and the impact on their children to be made. A UK Government warning was not issued until May 1962. One reason why researchers and doctors were slow to make this connection was due to the wide range of changes to foetal development. Limbs, internal organs including the brain, eyesight and hearing could all be affected.The first time the link between thalidomide and its impact on development was made public in a letter published in The Lancet from an Australian doctor William McBride, in 1961. The drug was formally withdrawn by Chemie Grünenthal on 26 November 1961 and a few days later, on 2 December 1961, the UK distributors followed suit. However, it remained in many medicine cabinets under many different names. In the few short years that thalidomide was available, it's estimated that over 10,000 babies were affected by the drug worldwide. Around half died within months of being born. The thalidomide babies who survived and their families live with the effects of the drug. The Thalidomide Society was formed in 1962 by the parents of children affected by the drug thalidomide. The original aim of the Society was to provide mutual support and a social network as well as to seek compensation. In 1972, a highly publicised campaign led by the Sunday Times newspaper helped to secure a further settlement for children affected by thalidomide in the UK. Thalidomide forced governments and medical authorities to review their pharmaceutical licencing policies. As a result, changes were made to the way drugs were marketed, tested and approved both in the UK and across the world. One key change was that drugs intended for human use could no longer be approved purely on the basis of animal testing. And drug trials for substances marketed to pregnant women also had to provide evidence that they were safe for use in pregnancy. ]]>
Thalidomide was first developed by CIBA, a Swiss pharmaceutical company in the early 1950s, and subsequently introduced as Contergan by Chemi Grunenthal. The drug was initially advertised as a sedative which would allow users to undergo a deep sleep in the absence of a hangover and with a reduced risk of developing drug dependency. At the time, basic testing was done on the drug, and it was considered not to have any toxic effects on humans. However, unlike today’s level of rigorous testing, the drug was not analyzed for any potentially dangerous teratogenic effects. In the 1950s, scientists did not know that the effects of a drug could be passed through the placental barrier and harm a foetus in the womb, so the use of medications during pregnancy was not strictly controlled. And in the case of thalidomide, no tests were done involving pregnant women. As the drug was traded under so many different names in 49 countries, it took five years for the connection between thalidomide taken by pregnant women and the impact on their children to be made. A UK Government warning was not issued until May 1962. One reason why researchers and doctors were slow to make this connection was due to the wide range of changes to foetal development. Limbs, internal organs including the brain, eyesight and hearing could all be affected.The first time the link between thalidomide and its impact on development was made public in a letter published in The Lancet from an Australian doctor William McBride, in 1961. The drug was formally withdrawn by Chemie Grünenthal on 26 November 1961 and a few days later, on 2 December 1961, the UK distributors followed suit. However, it remained in many medicine cabinets under many different names. In the few short years that thalidomide was available, it's estimated that over 10,000 babies were affected by the drug worldwide. Around half died within months of being born. The thalidomide babies who survived and their families live with the effects of the drug. The Thalidomide Society was formed in 1962 by the parents of children affected by the drug thalidomide. The original aim of the Society was to provide mutual support and a social network as well as to seek compensation. In 1972, a highly publicised campaign led by the Sunday Times newspaper helped to secure a further settlement for children affected by thalidomide in the UK. Thalidomide forced governments and medical authorities to review their pharmaceutical licencing policies. As a result, changes were made to the way drugs were marketed, tested and approved both in the UK and across the world. One key change was that drugs intended for human use could no longer be approved purely on the basis of animal testing. And drug trials for substances marketed to pregnant women also had to provide evidence that they were safe for use in pregnancy. ]]> Fri, 22 Apr 2022 05:36:40 GMT /slideshow/the-thalidomide-tragedypptx/251639143 KajalPradhan4@slideshare.net(KajalPradhan4) The Thalidomide tragedy.pptx KajalPradhan4 Thalidomide was first developed by CIBA, a Swiss pharmaceutical company in the early 1950s, and subsequently introduced as Contergan by Chemi Grunenthal. The drug was initially advertised as a sedative which would allow users to undergo a deep sleep in the absence of a hangover and with a reduced risk of developing drug dependency. At the time, basic testing was done on the drug, and it was considered not to have any toxic effects on humans. However, unlike today’s level of rigorous testing, the drug was not analyzed for any potentially dangerous teratogenic effects. In the 1950s, scientists did not know that the effects of a drug could be passed through the placental barrier and harm a foetus in the womb, so the use of medications during pregnancy was not strictly controlled. And in the case of thalidomide, no tests were done involving pregnant women. As the drug was traded under so many different names in 49 countries, it took five years for the connection between thalidomide taken by pregnant women and the impact on their children to be made. A UK Government warning was not issued until May 1962. One reason why researchers and doctors were slow to make this connection was due to the wide range of changes to foetal development. Limbs, internal organs including the brain, eyesight and hearing could all be affected.The first time the link between thalidomide and its impact on development was made public in a letter published in The Lancet from an Australian doctor William McBride, in 1961. The drug was formally withdrawn by Chemie Grünenthal on 26 November 1961 and a few days later, on 2 December 1961, the UK distributors followed suit. However, it remained in many medicine cabinets under many different names. In the few short years that thalidomide was available, it's estimated that over 10,000 babies were affected by the drug worldwide. Around half died within months of being born. The thalidomide babies who survived and their families live with the effects of the drug. The Thalidomide Society was formed in 1962 by the parents of children affected by the drug thalidomide. The original aim of the Society was to provide mutual support and a social network as well as to seek compensation. In 1972, a highly publicised campaign led by the Sunday Times newspaper helped to secure a further settlement for children affected by thalidomide in the UK. Thalidomide forced governments and medical authorities to review their pharmaceutical licencing policies. As a result, changes were made to the way drugs were marketed, tested and approved both in the UK and across the world. One key change was that drugs intended for human use could no longer be approved purely on the basis of animal testing. And drug trials for substances marketed to pregnant women also had to provide evidence that they were safe for use in pregnancy. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/thethalidomidetragedy-220422053640-thumbnail.jpg?width=120&height=120&fit=bounds" /> Thalidomide was first developed by CIBA, a Swiss pharmaceutical company in the early 1950s, and subsequently introduced as Contergan by Chemi Grunenthal. The drug was initially advertised as a sedative which would allow users to undergo a deep sleep in the absence of a hangover and with a reduced risk of developing drug dependency. At the time, basic testing was done on the drug, and it was considered not to have any toxic effects on humans. However, unlike today’s level of rigorous testing, the drug was not analyzed for any potentially dangerous teratogenic effects. In the 1950s, scientists did not know that the effects of a drug could be passed through the placental barrier and harm a foetus in the womb, so the use of medications during pregnancy was not strictly controlled. And in the case of thalidomide, no tests were done involving pregnant women. As the drug was traded under so many different names in 49 countries, it took five years for the connection between thalidomide taken by pregnant women and the impact on their children to be made. A UK Government warning was not issued until May 1962. One reason why researchers and doctors were slow to make this connection was due to the wide range of changes to foetal development. Limbs, internal organs including the brain, eyesight and hearing could all be affected.The first time the link between thalidomide and its impact on development was made public in a letter published in The Lancet from an Australian doctor William McBride, in 1961. The drug was formally withdrawn by Chemie Grünenthal on 26 November 1961 and a few days later, on 2 December 1961, the UK distributors followed suit. However, it remained in many medicine cabinets under many different names. In the few short years that thalidomide was available, it's estimated that over 10,000 babies were affected by the drug worldwide. Around half died within months of being born. The thalidomide babies who survived and their families live with the effects of the drug. The Thalidomide Society was formed in 1962 by the parents of children affected by the drug thalidomide. The original aim of the Society was to provide mutual support and a social network as well as to seek compensation. In 1972, a highly publicised campaign led by the Sunday Times newspaper helped to secure a further settlement for children affected by thalidomide in the UK. Thalidomide forced governments and medical authorities to review their pharmaceutical licencing policies. As a result, changes were made to the way drugs were marketed, tested and approved both in the UK and across the world. One key change was that drugs intended for human use could no longer be approved purely on the basis of animal testing. And drug trials for substances marketed to pregnant women also had to provide evidence that they were safe for use in pregnancy.

The Thalidomide tragedy.pptx from kajal pradhan

]]> 7861 0 https://cdn.slidesharecdn.com/ss_thumbnails/thethalidomidetragedy-220422053640-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Hair sturcture and hair cycle /slideshow/hair-sturcture-and-hair-cycle/249693674 hair1-210712043725
Anagen : Anagen is the active growth stage of hair. During the anagen stage the hair contain it’s highest amount of melanin. This stage is lasts between 3-6 years. Catagen: Catagen is a transition stage in which the hair stops growing but the hair is not shed. During this stage the follicle is being reabsorbed . This stage lasts 2-3 weeks. Telogen: Telegen is a resting stage during which the follicle receds and the hair begin to fall in preparation for the development of new hair. This stage lasts between 6-8 weeks. Anagen: The hair growth cycle continues as anagen begins again. The old hair has shed and a new follicle has formed. A new hair begins growing to replace the hair that was shed. ]]>
Anagen : Anagen is the active growth stage of hair. During the anagen stage the hair contain it’s highest amount of melanin. This stage is lasts between 3-6 years. Catagen: Catagen is a transition stage in which the hair stops growing but the hair is not shed. During this stage the follicle is being reabsorbed . This stage lasts 2-3 weeks. Telogen: Telegen is a resting stage during which the follicle receds and the hair begin to fall in preparation for the development of new hair. This stage lasts between 6-8 weeks. Anagen: The hair growth cycle continues as anagen begins again. The old hair has shed and a new follicle has formed. A new hair begins growing to replace the hair that was shed. ]]> Mon, 12 Jul 2021 04:37:24 GMT /slideshow/hair-sturcture-and-hair-cycle/249693674 KajalPradhan4@slideshare.net(KajalPradhan4) Hair sturcture and hair cycle KajalPradhan4 Anagen : Anagen is the active growth stage of hair. During the anagen stage the hair contain it’s highest amount of melanin. This stage is lasts between 3-6 years. Catagen: Catagen is a transition stage in which the hair stops growing but the hair is not shed. During this stage the follicle is being reabsorbed . This stage lasts 2-3 weeks. Telogen: Telegen is a resting stage during which the follicle receds and the hair begin to fall in preparation for the development of new hair. This stage lasts between 6-8 weeks. Anagen: The hair growth cycle continues as anagen begins again. The old hair has shed and a new follicle has formed. A new hair begins growing to replace the hair that was shed. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/hair1-210712043725-thumbnail.jpg?width=120&height=120&fit=bounds" /> Anagen : Anagen is the active growth stage of hair. During the anagen stage the hair contain it’s highest amount of melanin. This stage is lasts between 3-6 years. Catagen: Catagen is a transition stage in which the hair stops growing but the hair is not shed. During this stage the follicle is being reabsorbed . This stage lasts 2-3 weeks. Telogen: Telegen is a resting stage during which the follicle receds and the hair begin to fall in preparation for the development of new hair. This stage lasts between 6-8 weeks. Anagen: The hair growth cycle continues as anagen begins again. The old hair has shed and a new follicle has formed. A new hair begins growing to replace the hair that was shed.

Hair sturcture and hair cycle from kajal pradhan

]]> 1236 0 https://cdn.slidesharecdn.com/ss_thumbnails/hair1-210712043725-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Concept of health /slideshow/concept-of-health-242282666/242282666 conceptofhealth-210205032550
What is Health? Acc. to WHO 1948, Health is a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity. What is Disease? A disease is a particular abnormal condition that negatively affects the structure or function of all or part of an organism, and that is not due to any immediate external injury. What is “Germ theory of Disease”? The germ theory states that many diseases are caused by the growth and reproduction of specific microorganisms within a host body. ]]>
What is Health? Acc. to WHO 1948, Health is a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity. What is Disease? A disease is a particular abnormal condition that negatively affects the structure or function of all or part of an organism, and that is not due to any immediate external injury. What is “Germ theory of Disease”? The germ theory states that many diseases are caused by the growth and reproduction of specific microorganisms within a host body. ]]> Fri, 05 Feb 2021 03:25:50 GMT /slideshow/concept-of-health-242282666/242282666 KajalPradhan4@slideshare.net(KajalPradhan4) Concept of health KajalPradhan4 What is Health? Acc. to WHO 1948, Health is a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity. What is Disease? A disease is a particular abnormal condition that negatively affects the structure or function of all or part of an organism, and that is not due to any immediate external injury. What is “Germ theory of Disease”? The germ theory states that many diseases are caused by the growth and reproduction of specific microorganisms within a host body. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/conceptofhealth-210205032550-thumbnail.jpg?width=120&height=120&fit=bounds" /> What is Health? Acc. to WHO 1948, Health is a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity. What is Disease? A disease is a particular abnormal condition that negatively affects the structure or function of all or part of an organism, and that is not due to any immediate external injury. What is “Germ theory of Disease”? The germ theory states that many diseases are caused by the growth and reproduction of specific microorganisms within a host body.

Concept of health from kajal pradhan

]]> 187 0 https://cdn.slidesharecdn.com/ss_thumbnails/conceptofhealth-210205032550-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Pelletization /slideshow/pelletization-241589193/241589193 pelletization-210120071741
pellets can be defined as multi particulate system or multiunit system They are spherical particulates manufactured by agglomeration of the powder granules containing drug substance and excipients. Pellets can be prepared by a special technique called Pelletization. This technique is referred to an agglomeration process that convert fine powder or granules of bulk drug or excipient in to small , free flowing , spherical or semi spherical pellets . Multi particular drug delivery system especially suitable for achieving controlled delay released oral formulation with low risk of dose dumping, flexibility of blending to attain different release patterns as well as reproducible and short gastric residence time. Multi particulate drug delivery system are mainly oral dosage form consisting of a multiplicity of small discrete units each exhibiting some desire characteristics. ]]>
pellets can be defined as multi particulate system or multiunit system They are spherical particulates manufactured by agglomeration of the powder granules containing drug substance and excipients. Pellets can be prepared by a special technique called Pelletization. This technique is referred to an agglomeration process that convert fine powder or granules of bulk drug or excipient in to small , free flowing , spherical or semi spherical pellets . Multi particular drug delivery system especially suitable for achieving controlled delay released oral formulation with low risk of dose dumping, flexibility of blending to attain different release patterns as well as reproducible and short gastric residence time. Multi particulate drug delivery system are mainly oral dosage form consisting of a multiplicity of small discrete units each exhibiting some desire characteristics. ]]> Wed, 20 Jan 2021 07:17:40 GMT /slideshow/pelletization-241589193/241589193 KajalPradhan4@slideshare.net(KajalPradhan4) Pelletization KajalPradhan4 pellets can be defined as multi particulate system or multiunit system They are spherical particulates manufactured by agglomeration of the powder granules containing drug substance and excipients. Pellets can be prepared by a special technique called Pelletization. This technique is referred to an agglomeration process that convert fine powder or granules of bulk drug or excipient in to small , free flowing , spherical or semi spherical pellets . Multi particular drug delivery system especially suitable for achieving controlled delay released oral formulation with low risk of dose dumping, flexibility of blending to attain different release patterns as well as reproducible and short gastric residence time. Multi particulate drug delivery system are mainly oral dosage form consisting of a multiplicity of small discrete units each exhibiting some desire characteristics. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/pelletization-210120071741-thumbnail.jpg?width=120&height=120&fit=bounds" /> pellets can be defined as multi particulate system or multiunit system They are spherical particulates manufactured by agglomeration of the powder granules containing drug substance and excipients. Pellets can be prepared by a special technique called Pelletization. This technique is referred to an agglomeration process that convert fine powder or granules of bulk drug or excipient in to small , free flowing , spherical or semi spherical pellets . Multi particular drug delivery system especially suitable for achieving controlled delay released oral formulation with low risk of dose dumping, flexibility of blending to attain different release patterns as well as reproducible and short gastric residence time. Multi particulate drug delivery system are mainly oral dosage form consisting of a multiplicity of small discrete units each exhibiting some desire characteristics.

Pelletization from kajal pradhan

]]> 30231 0 https://cdn.slidesharecdn.com/ss_thumbnails/pelletization-210120071741-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Surface and Interfacial tension /slideshow/surface-and-interfacial-tension-240884031/240884031 physicalpharmacysem-3-210104050802
When phases exist together, the boundary between two of them is known as interface. When the phase is in contact with atmosphere it is termed as surface. ]]>
When phases exist together, the boundary between two of them is known as interface. When the phase is in contact with atmosphere it is termed as surface. ]]> Mon, 04 Jan 2021 05:08:02 GMT /slideshow/surface-and-interfacial-tension-240884031/240884031 KajalPradhan4@slideshare.net(KajalPradhan4) Surface and Interfacial tension KajalPradhan4 When phases exist together, the boundary between two of them is known as interface. When the phase is in contact with atmosphere it is termed as surface. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/physicalpharmacysem-3-210104050802-thumbnail.jpg?width=120&height=120&fit=bounds" /> When phases exist together, the boundary between two of them is known as interface. When the phase is in contact with atmosphere it is termed as surface.

Surface and Interfacial tension from kajal pradhan

]]> 9323 0 https://cdn.slidesharecdn.com/ss_thumbnails/physicalpharmacysem-3-210104050802-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Sustained release oral dosage forms /slideshow/sustained-release-oral-dosage-forms-216994302/216994302 sustainedreleaseoraldosageforms-200108065950
]]>
]]> Wed, 08 Jan 2020 06:59:50 GMT /slideshow/sustained-release-oral-dosage-forms-216994302/216994302 KajalPradhan4@slideshare.net(KajalPradhan4) Sustained release oral dosage forms KajalPradhan4 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/sustainedreleaseoraldosageforms-200108065950-thumbnail.jpg?width=120&height=120&fit=bounds" />

Sustained release oral dosage forms from kajal pradhan

]]> 356 0 https://cdn.slidesharecdn.com/ss_thumbnails/sustainedreleaseoraldosageforms-200108065950-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Confidentiality /slideshow/confidentiality-208924568/208924568 confidentiality-191222045313
Confidentiality can be defined as the ethical principle or legal right that a physician or other health professional will hold secret all information relating to a patient, unless the patient gives consent permitting disclosure.]]>
Confidentiality can be defined as the ethical principle or legal right that a physician or other health professional will hold secret all information relating to a patient, unless the patient gives consent permitting disclosure.]]> Sun, 22 Dec 2019 04:53:13 GMT /slideshow/confidentiality-208924568/208924568 KajalPradhan4@slideshare.net(KajalPradhan4) Confidentiality KajalPradhan4 Confidentiality can be defined as the ethical principle or legal right that a physician or other health professional will hold secret all information relating to a patient, unless the patient gives consent permitting disclosure. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/confidentiality-191222045313-thumbnail.jpg?width=120&height=120&fit=bounds" /> Confidentiality can be defined as the ethical principle or legal right that a physician or other health professional will hold secret all information relating to a patient, unless the patient gives consent permitting disclosure.

Confidentiality from kajal pradhan

]]> 3253 0 https://cdn.slidesharecdn.com/ss_thumbnails/confidentiality-191222045313-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Herbal cosmetics seminar /slideshow/herbal-cosmetics-seminar/134946851 herbalcosmeticsseminar-190306172126
challenges during formulating herbal cosmetics]]>
challenges during formulating herbal cosmetics]]> Wed, 06 Mar 2019 17:21:26 GMT /slideshow/herbal-cosmetics-seminar/134946851 KajalPradhan4@slideshare.net(KajalPradhan4) Herbal cosmetics seminar KajalPradhan4 challenges during formulating herbal cosmetics <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/herbalcosmeticsseminar-190306172126-thumbnail.jpg?width=120&height=120&fit=bounds" /> challenges during formulating herbal cosmetics

Herbal cosmetics seminar from kajal pradhan

]]> 1684 6 https://cdn.slidesharecdn.com/ss_thumbnails/herbalcosmeticsseminar-190306172126-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Types of crystals & Application of x ray /slideshow/types-of-crystals-application-of-x-ray/124956440 applicationofx-ray-181204185529
some basic information:- A crystal lattice is a 3-D arrangement of unit cells. Unit cell is the smallest unit of a crystal, By stacking identical unit cells, the entire lattice can be constructed A crystal’s unit cell dimensions are defined by six numbers, the lengths of the 3 axes, a, b, and c, and the three interaxial angles, α, β and γ. If a unit cell has the same type of atom at the corners of the unit cell but not also in the middle of the faces nor in the centre of the cell, it is called primitive and given by symbol P 7 types of crystal system details 14 bravis lattice APPLICATION X-RAY CRYSTALLOGRAPHY 1. Structure of crystals 2. Polymer characterisation 3. State of anneal in metals 4. Particle size determination a) Spot counting method b) Broadening of diffraction lines c) Low-angle scattering 5.Applications of diffraction methods to complexes a) Determination of cis- trans isomerism b) Determination of linkage isomerism 6.Miscellaneous applications ]]>
some basic information:- A crystal lattice is a 3-D arrangement of unit cells. Unit cell is the smallest unit of a crystal, By stacking identical unit cells, the entire lattice can be constructed A crystal’s unit cell dimensions are defined by six numbers, the lengths of the 3 axes, a, b, and c, and the three interaxial angles, α, β and γ. If a unit cell has the same type of atom at the corners of the unit cell but not also in the middle of the faces nor in the centre of the cell, it is called primitive and given by symbol P 7 types of crystal system details 14 bravis lattice APPLICATION X-RAY CRYSTALLOGRAPHY 1. Structure of crystals 2. Polymer characterisation 3. State of anneal in metals 4. Particle size determination a) Spot counting method b) Broadening of diffraction lines c) Low-angle scattering 5.Applications of diffraction methods to complexes a) Determination of cis- trans isomerism b) Determination of linkage isomerism 6.Miscellaneous applications ]]> Tue, 04 Dec 2018 18:55:29 GMT /slideshow/types-of-crystals-application-of-x-ray/124956440 KajalPradhan4@slideshare.net(KajalPradhan4) Types of crystals & Application of x ray KajalPradhan4 some basic information:- A crystal lattice is a 3-D arrangement of unit cells. Unit cell is the smallest unit of a crystal, By stacking identical unit cells, the entire lattice can be constructed A crystal’s unit cell dimensions are defined by six numbers, the lengths of the 3 axes, a, b, and c, and the three interaxial angles, α, β and γ. If a unit cell has the same type of atom at the corners of the unit cell but not also in the middle of the faces nor in the centre of the cell, it is called primitive and given by symbol P 7 types of crystal system details 14 bravis lattice APPLICATION X-RAY CRYSTALLOGRAPHY 1. Structure of crystals 2. Polymer characterisation 3. State of anneal in metals 4. Particle size determination a) Spot counting method b) Broadening of diffraction lines c) Low-angle scattering 5.Applications of diffraction methods to complexes a) Determination of cis- trans isomerism b) Determination of linkage isomerism 6.Miscellaneous applications <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/applicationofx-ray-181204185529-thumbnail.jpg?width=120&height=120&fit=bounds" /> some basic information:- A crystal lattice is a 3-D arrangement of unit cells. Unit cell is the smallest unit of a crystal, By stacking identical unit cells, the entire lattice can be constructed A crystal’s unit cell dimensions are defined by six numbers, the lengths of the 3 axes, a, b, and c, and the three interaxial angles, α, β and γ. If a unit cell has the same type of atom at the corners of the unit cell but not also in the middle of the faces nor in the centre of the cell, it is called primitive and given by symbol P 7 types of crystal system details 14 bravis lattice APPLICATION X-RAY CRYSTALLOGRAPHY 1. Structure of crystals 2. Polymer characterisation 3. State of anneal in metals 4. Particle size determination a) Spot counting method b) Broadening of diffraction lines c) Low-angle scattering 5.Applications of diffraction methods to complexes a) Determination of cis- trans isomerism b) Determination of linkage isomerism 6.Miscellaneous applications

Types of crystals & Application of x ray from kajal pradhan

]]> 12638 1 https://cdn.slidesharecdn.com/ss_thumbnails/applicationofx-ray-181204185529-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 sustained release oral dosage forms /slideshow/sustained-release-oral-dosage-forms/119887915 finaldocumentak-181018122542
assignment on sustained release oral dosage form-including Matrix tablets]]>
assignment on sustained release oral dosage form-including Matrix tablets]]> Thu, 18 Oct 2018 12:25:42 GMT /slideshow/sustained-release-oral-dosage-forms/119887915 KajalPradhan4@slideshare.net(KajalPradhan4) sustained release oral dosage forms KajalPradhan4 assignment on sustained release oral dosage form-including Matrix tablets <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/finaldocumentak-181018122542-thumbnail.jpg?width=120&height=120&fit=bounds" /> assignment on sustained release oral dosage form-including Matrix tablets

sustained release oral dosage forms from kajal pradhan

]]> 793 1 https://cdn.slidesharecdn.com/ss_thumbnails/finaldocumentak-181018122542-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 https://public.slidesharecdn.com/v2/images/profile-picture.png https://cdn.slidesharecdn.com/ss_thumbnails/rheology-240208083817-71c0c770-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/rheology-types-of-fluid-flow-viscometer/266214141 rheology, types of flu... https://cdn.slidesharecdn.com/ss_thumbnails/emulsionandsuspension-221123054021-f35a5178-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/emulsion-and-suspensionpptx/254425380 Emulsion and Suspensio... https://cdn.slidesharecdn.com/ss_thumbnails/whyusethezebrafishinresearch-221115043748-b13c67a1-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/why-use-the-zebrafish-in-researchpptx/254206695 Why use the zebrafish ...